Vedanta biosciences to present at upcoming investor conferences

Cambridge, mass.--(business wire)--vedanta biosciences, a leading clinical-stage microbiome company developing a new category of oral therapies using rationally defined bacterial consortia manufactured from clonal cell banks, today announced that members of its executive team will present and host one-on-one meetings at the following virtual investor conferences: chardan 3rd annual microbiome medicines summit date: monday, march 8, 2021 presentation time: 2:00 pm et h.c. wainwright global life
PRTC Ratings Summary
PRTC Quant Ranking